David Taggart

Dave Taggart is the Founder and Chief Business Officer at Glycyx MOR, Inc., a pharmaceutical company focused on improving immunotherapy for cancer patients. Dave also served as a Board Member and Biomed Lead at the Isle of Man Department for Enterprise. With a background in medical market research and consulting, Dave has held various leadership roles in companies such as Glycyx Therapeutics, Vorpal Technologies K.K., and Juniper Consulting. Dave has a Master of Laws (LLM) in Innovation, Technology & Law from the University of Edinburgh, an MSc in International Relations from The London School of Economics and Political Science, and a BA in History from the University of Oxford.